CD4 and type 1 diabetes mellitus: The mechanisms by which MHC molecules control autoimmunity are still not understood but recent advances in the molecular characterization of peptide-MHC complexes targeted by autoreactive CD4+ T cells in type 1 diabetes (T1D) and other autoimmune diseases have shed some light on this issue [49].